 The use of nanotechnology in medicine has the potential to revolutionize the way we treat disease. Nanoparticle-based medications, nanomedicines, offer a promising alternative to traditional pharmaceuticals by providing more efficient and targeted delivery of drugs. However, there are many challenges associated with bringing these products to market, such as biological challenges, large-scale manufacturing, biocompatibility and safety, intellectual property, IP, government regulation and cost-effectiveness. Despite these obstacles, nanomedicines hold great promise for improving patient outcomes and reducing the cost of care. This article was authored by Susan Hua, Susan Hua, Maria B.C. DeMotto's and others.